课题基金 / 基金详情

Molecular Mechanism and i Therapy for Choroidal Neovascularization

Molecular Mechanism and i Therapy for Choroidal Neovascularization
脉络膜新生血管的分子机制及治疗
批准号:
14571694
负责人:
OGATA Nahoko
金额:
$2.24万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2003

项目摘要

项目成果

OGATA Nahoko的其他基金

相似基金

相关文献

中文摘要
翻译
血管生成被认为是由刺激因子(如血管内皮生长因子(VEGF))或抑制剂(如色素上皮衍生因子(PEDF))的平衡控制的。我们发现糖尿病视网膜病变眼玻璃体中PEDF水平较低,VEGF水平较高,这说明糖尿病视网膜病变眼中血管生成刺激剂和抑制剂的平衡被打破。此外,增生性玻璃体视网膜病变眼PEDF水平较低。在孔源性视网膜脱离的眼中较高,表明PEDF也控制着眼细胞的增殖。在实验性脉络膜新生血管的形成过程中,血管内皮细胞中有较强的VEGF和PEDF表达,随后逐渐下降,PEDF在RPE细胞中表达。这些发现提示PEDF和VEGF可能调节脉络膜新生血管的形成过程。在人眼中,PEDF和VEGF在活动性脉络膜新生血管(cnvm)和息肉样脉络膜病变的血管内皮细胞和视网膜色素上皮(RPE)细胞中表达强烈,而PEDF和VEGF在静态脉络膜新生血管(cnvm)中表达较弱。我们的结果表明PEDF和VEGF可能调节中央凹下纤维血管膜的形成。PEDF水平随着年龄的增长而下降。在与年龄有关的眼病,特别是与血管生成有关的眼病中,应考虑PEDF水平与年龄的负相关。视网膜色素变性和晚期青光眼组PEDF水平明显低于单纯白内障组。在患有神经视网膜营养不良的眼睛中,PEDF水平较低可能与合成PEDF的视网膜神经节细胞和/或RPE细胞的丧失有关。
英文摘要
Angiogenesis is believed to be controlled by a balance of stimulators such as vascular endothelial growth factor(VEGF), or inhibitors such as pigment epithelium-derived factor(PEDF).We found that the level of PEDF was lower and the level of VEGF was high in the vitreous of eyes with diabetic retinopathy, These results indicate that there is an upset balance of angiogenic stimulators and inhibitors in eye with diabetic retinopathy. In addition, the level of PEDF was lower in eyes with proliferative vitreoretinopathy. and high in eyes with rhegmatogenous retinal detachment, which indicates that PEDF is also controlling ocular cell proliferation.During the development of experimental choroidal neovascularization, VEGF and also PEDF were strongly detected in vascular endothelial cells, then gradually declined and PEDF was expressed in the RPE cells. These findings suggest that PEDF and VEGF may modulate the process of choroidal neovascularization.In human eyes, PEDF and VEGF were strongly expressed in the vascular endothelial cells and retinal pigment epithelial(RPE) cells in active choroidal neovascular membranes(CNVMs) and polypoidal choroidal vasculopathy, whereas PEDF and VEGF, were both weak in quiescent CNVMs. Our results suggest that PEDF along with VEGF may modulate the formation of subfoveal fibrovascular membranes.The PEDF levels decreased with increasing age. The negative correlation of PEDF level and age should be considered in age-related eye diseases especially those associated with angiogenesis.he mean levels of PEDF in eyes with retinitis pigmentosa and advanced glaucoma were significantly lower than that in eyes with cataract alone. The lower levels of PEDF in eyes with neuroretinal dystrophy may be related to the loss of the retinal ganglion cells and/or RPE cells that synthesize PEDF.
期刊论文(82)
专著(0)
科研奖励(0)
会议论文
Nahoko Ogata, Mitsumasa Wada, Tsuyoshi Otsuji, et al.: "Expression of pigment epithelium-derived factor in normal adult rat eye and experimental choroidal neovscularization"Investigative Ophthalmology & Visual Science. 43. 1168-1175 (2002)
Nahoko Ogata、Mitsumasa Wada、Tsuyoshi Otsuji 等人:“正常成年大鼠眼中色素上皮衍生因子的表达和实验性脉络膜新生血管” 眼科研究
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Jo Nobuo, Ogata N, et al.: "Effective transfection of a cis element "decoy" of the nuclear factor κ-B binding site into the experimental choroifdal neovacularization."Current Eye Research. 24. 465-473 (2002)
Jo Nobuo、Ogata N 等人:“将核因子 κ-B 结合位点的顺式元件“诱饵”有效转染至实验性脉络膜新生血管中。”Current Eye Research 24. 465-473 (2002)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
緒方 奈保子: "眼科医にとって理想のタンパクPigment Epithelium-Derived Factor(PEDF"あたらしい眼科. 20. 1261-1263 (2003)
Naoko Ogata:“色素上皮衍生因子 (PEDF),眼科医生的理想蛋白质。新眼科。20. 1261-1263 (2003)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 38 条
    Molecular biological study and treatment for diabetic retinopathy
    • 批准号:
      18591943
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.51万
    • 财政年份:
      2006
    • 负责人:
      OGATA Nahoko
    • 依托单位:
    Molecular biological analysis and treatment for diabetic retinopathy
    • 批准号:
      16591774
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.92万
    • 财政年份:
      2004
    • 负责人:
      OGATA Nahoko
    • 依托单位:
    Control of Ocular Proliferation and Neuroprotection by Gene Therapy and Analysis of These Molecular Mechanisms.
    • 批准号:
      12671730
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.5万
    • 财政年份:
      2000
    • 负责人:
      OGATA Nahoko
    • 依托单位:
    Gene Therapy and Transplantation of Retinal Pigment Epithelium for Ocular Proliferative Deseases and Retinal Degeneration
    • 批准号:
      10671662
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.98万
    • 财政年份:
      1998
    • 负责人:
      OGATA Nahoko
    • 依托单位:
    国内基金
    海外基金
    基于VEGF/VEGFR信号通路探讨自拟创疡膏对慢性创面的作用机制研究
    • 批准号:
      2026JJ80680
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      姜平
    • 依托单位:
    协同靶向VE-PTP/VEGF重建胶质母细胞瘤血管稳态的双靶点抑制剂开发与机制研究
    • 批准号:
      JCZRLH202601503
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
    • 依托单位:
    RNA 结合蛋白HuR与VEGF-D联合调控舌鳞癌侵袭及转移机制的研究
    • 批准号:
      2026JJ80684
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      龚攀
    • 依托单位: